Correction: Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
| Published in: | Journal of Cancer Research and Clinical Oncology |
|---|---|
| Main Authors: | Shanqi Li, Yuzhou Qian, Wanchen Xie, Xinyu Li, Jiaying Wei, Long Wang, Guosheng Ren, Xuedong Yin |
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Online Access: | https://doi.org/10.1007/s00432-024-06048-y |
Similar Items
Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-03-01)
by: Shanqi Li, et al.
Published: (2024-03-01)
Triple-negative breast cancer molecular subtyping and treatment progress
by: Li Yin, et al.
Published: (2020-06-01)
by: Li Yin, et al.
Published: (2020-06-01)
Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)
by: Xinyu Ren, et al.
Published: (2025-04-01)
Components of the tumor immune microenvironment based on m‐IHC correlate with prognosis and subtype of triple‐negative breast cancer
by: Luyi Lin, et al.
Published: (2023-12-01)
by: Luyi Lin, et al.
Published: (2023-12-01)
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
by: Xi Chen, et al.
Published: (2012-07-01)
by: Xi Chen, et al.
Published: (2012-07-01)
Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
by: Srijan Basu, et al.
Published: (2023-11-01)
by: Srijan Basu, et al.
Published: (2023-11-01)
Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer
by: WANG Yajuan, et al.
Published: (2024-04-01)
by: WANG Yajuan, et al.
Published: (2024-04-01)
Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
by: Chanjuan Zheng, et al.
Published: (2023-07-01)
by: Chanjuan Zheng, et al.
Published: (2023-07-01)
Heterogeneity of anoikis in triple-negative breast cancer subtyping and therapeutic implications
by: Kun Fang, et al.
Published: (2025-01-01)
by: Kun Fang, et al.
Published: (2025-01-01)
Comparison of Mammography Findings of Triple Negative Breast Cancer with Non Triple Negative Breast Cancer Subtypes: A Retrospective Observational Study
by: Sujata Panta, et al.
Published: (2025-04-01)
by: Sujata Panta, et al.
Published: (2025-04-01)
Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer
by: Ren K, et al.
Published: (2018-10-01)
by: Ren K, et al.
Published: (2018-10-01)
Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data
by: Kaiyuan Xing, et al.
Published: (2023-01-01)
by: Kaiyuan Xing, et al.
Published: (2023-01-01)
Integrating radiosensitivity index and triple‐negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple‐negative breast cancer
by: Xinxin Rao, et al.
Published: (2024-08-01)
by: Xinxin Rao, et al.
Published: (2024-08-01)
Rare subtypes of triple negative breast cancer: Current understanding and future directions
by: Alexandra Thomas, et al.
Published: (2023-06-01)
by: Alexandra Thomas, et al.
Published: (2023-06-01)
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
by: Tong L, et al.
Published: (2023-08-01)
by: Tong L, et al.
Published: (2023-08-01)
Mesenchymal Subtype of Triple-Negative Breast Cancer: A Review of Specific Features
by: Nadezhda V. Krakhmal, et al.
Published: (2023-03-01)
by: Nadezhda V. Krakhmal, et al.
Published: (2023-03-01)
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
by: Pascal Jézéquel, et al.
Published: (2019-05-01)
by: Pascal Jézéquel, et al.
Published: (2019-05-01)
Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer
by: Shuang-Long Cai, et al.
Published: (2023-02-01)
by: Shuang-Long Cai, et al.
Published: (2023-02-01)
Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
by: Yangyang Guo, et al.
Published: (2023-06-01)
by: Yangyang Guo, et al.
Published: (2023-06-01)
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
by: Miquel Ensenyat-Mendez, et al.
Published: (2021-06-01)
by: Miquel Ensenyat-Mendez, et al.
Published: (2021-06-01)
Quantifying spatial CXCL9 distribution with image analysis predicts improved prognosis of triple-negative breast cancer
by: Xi Cao, et al.
Published: (2024-06-01)
by: Xi Cao, et al.
Published: (2024-06-01)
Association of lncRNA AGAP11 with prognosis and malignant progression in triple-negative breast cancer
by: Guihua Fu, et al.
Published: (2026-03-01)
by: Guihua Fu, et al.
Published: (2026-03-01)
Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
by: Sainan Liu, et al.
Published: (2021-05-01)
by: Sainan Liu, et al.
Published: (2021-05-01)
Identification of tumor associated neutrophils-related genes in triple-negative breast cancer for predicting prognosis and therapeutic response through integrated single-cell analysis
by: Koukou Li, et al.
Published: (2025-09-01)
by: Koukou Li, et al.
Published: (2025-09-01)
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer
by: Xiuzhi Zhu, et al.
Published: (2024-09-01)
by: Xiuzhi Zhu, et al.
Published: (2024-09-01)
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review
by: Jie H, et al.
Published: (2025-03-01)
by: Jie H, et al.
Published: (2025-03-01)
Bioinformatics analysis for immune hub genes in BLIS subtype of triple-negative breast cancer
by: Hend Adel, et al.
Published: (2025-07-01)
by: Hend Adel, et al.
Published: (2025-07-01)
Development of a Cell line Classifier for Precision Subtyping of Triple-Negative Breast Cancer
by: Lu Zhilin, et al.
Published: (2025-01-01)
by: Lu Zhilin, et al.
Published: (2025-01-01)
Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers
by: Rima Saad Bouzid, et al.
Published: (2025-03-01)
by: Rima Saad Bouzid, et al.
Published: (2025-03-01)
Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
by: Marisa Leeha, et al.
Published: (2023-05-01)
by: Marisa Leeha, et al.
Published: (2023-05-01)
SA 9.3 Tackling triple negative histological subtypes in early breast cancer
by: J. Reis Filho
Published: (2023-03-01)
by: J. Reis Filho
Published: (2023-03-01)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
by: Brian D Lehmann, et al.
Published: (2016-01-01)
by: Brian D Lehmann, et al.
Published: (2016-01-01)
Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
by: Ran Ding, et al.
Published: (2023-06-01)
by: Ran Ding, et al.
Published: (2023-06-01)
A case report and literature review on a rare subtype of triple-negative breast cancer in children
by: Lexiang Shi, et al.
Published: (2023-09-01)
by: Lexiang Shi, et al.
Published: (2023-09-01)
Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients
by: Shi H, et al.
Published: (2019-12-01)
by: Shi H, et al.
Published: (2019-12-01)
Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer
by: Xingyu Li, et al.
Published: (2024-01-01)
by: Xingyu Li, et al.
Published: (2024-01-01)
The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.
by: Ziyao Li, et al.
Published: (2015-01-01)
by: Ziyao Li, et al.
Published: (2015-01-01)
Loss of miR-634 contributes to the formation FOXA1-positive triple negative breast cancer subtype
by: Feng Ren, et al.
Published: (2024-10-01)
by: Feng Ren, et al.
Published: (2024-10-01)
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
by: Noor A. M. Bakker, et al.
Published: (2025-01-01)
by: Noor A. M. Bakker, et al.
Published: (2025-01-01)
C-FOS promotes the formation of neutrophil extracellular traps and the recruitment of neutrophils in lung metastasis of triple-negative breast cancer
by: Shuai Yan, et al.
Published: (2025-03-01)
by: Shuai Yan, et al.
Published: (2025-03-01)
Similar Items
-
Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-03-01) -
Triple-negative breast cancer molecular subtyping and treatment progress
by: Li Yin, et al.
Published: (2020-06-01) -
Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01) -
Components of the tumor immune microenvironment based on m‐IHC correlate with prognosis and subtype of triple‐negative breast cancer
by: Luyi Lin, et al.
Published: (2023-12-01) -
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
by: Xi Chen, et al.
Published: (2012-07-01)
